A detailed history of Asset Planning Corporation transactions in Amgen Inc stock. As of the latest transaction made, Asset Planning Corporation holds 758 shares of AMGN stock, worth $219,744. This represents 0.16% of its overall portfolio holdings.

Number of Shares
758
Previous 758 -0.0%
Holding current value
$219,744
Previous $236,000 3.39%
% of portfolio
0.16%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$262.75 - $319.31 $59,118 - $71,844
-225 Reduced 22.89%
758 $236,000
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $60,495 - $73,026
-225 Reduced 18.63%
983 $279,000
Q4 2022

Jan 27, 2023

BUY
$229.03 - $291.01 $276,668 - $351,540
1,208 New
1,208 $0
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $104,297 - $121,542
-470 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $101,698 - $121,104
470 New
470 $108,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Asset Planning Corporation Portfolio

Follow Asset Planning Corporation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Planning Corporation, based on Form 13F filings with the SEC.

News

Stay updated on Asset Planning Corporation with notifications on news.